Nonetheless, the success of rescuing neuronal signalling and behavioural abnormalities in Fmr1 KO mice by genetic and pharmacological reduction of ADCY1 function suggests that ADCY1-coupled signalling is a major factor for pathophysiology in the mouse model of FXS. This evidence concerns the gene ADCY1 and fragile X syndrome.